Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System

<b>Background/Objectives</b>: Monoclonal antibodies (mAbs) have revolutionized multiple myeloma (MM) treatment. However, post-marketing data on their neuropsychiatric safety are limited. This study aimed to evaluate neuropsychiatric adverse events (AEs) related to mAbs used for MM throug...

Full description

Saved in:
Bibliographic Details
Main Authors: Giuseppe Cicala (Author), Giulia Russo (Author), Vincenza Santoro (Author), Tindara Franchina (Author), Nicola Silvestris (Author), Mariacarmela Santarpia (Author), Edoardo Spina (Author), Maria Antonietta Barbieri (Author)
Format: Book
Published: MDPI AG, 2024-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available